These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9188948)

  • 1. Nasal immunotherapy in pollen-sensitive children.
    Cserháti E; Mezei G
    Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
    Ariano R; Panzani RC; Chiapella M; Augeri G; Falagiani P
    J Investig Allergol Clin Immunol; 1995; 5(3):126-32. PubMed ID: 7582157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
    Bertoni M; Cosmi F; Bianchi I; Di Berardino L
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial.
    Caffarelli C; Sensi LG; Marcucci F; Cavagni G
    Allergy; 2000 Dec; 55(12):1142-7. PubMed ID: 11117271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
    Winther L; Malling HJ; Mosbech H
    Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
    Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific nasal provocation test with powder allergen.
    Salzano FA
    Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
    Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
    J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
    Senna GE; Andri G; Dama AR; Falagiani P; Andri L
    Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
    Ford SA; Baroody FM; Naclerio RM
    Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
    [No Abstract]   [Full Text] [Related]  

  • 13. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of local nasal immunotherapy.
    Andri L; Senna GE; Dama AR
    Allergy; 1997; 52(33 Suppl):36-9. PubMed ID: 9188947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen.
    Blanca-Lopez N; Campo P; Salas M; García Rodríguez C; Palomares F; Blanca M; Canto G; Feo Brito F; Rondon C
    J Investig Allergol Clin Immunol; 2016; 26(2):83-91. PubMed ID: 27164623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunotherapy and polymerized grass pollen allergens.
    Schumacher MJ; Pain MC
    Allergy; 1982 May; 37(4):241-8. PubMed ID: 6814284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with grass pollen major allergens.
    Osterballe O
    Allergy; 1982 Aug; 37(6):379-88. PubMed ID: 7137533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization.
    Taudorf E; Laursen LC; Djurup R; Kappelgaard E; Pedersen CT; Søborg M; Wilkinson P; Weeke B
    Allergy; 1985 Jul; 40(5):321-35. PubMed ID: 3898904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.